Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews · Headline outcomes only

No studies found 1 · 33.3%GRADE not reported 0 · 0%Very low 2 · 66.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Nausea · people with moderate to severe cancer pain

It is very uncertain whether hydromorphone changes specific adverse events – nausea compared with morphine (very low certainty).

1 finding from 1 review

Hydromorphone for cancer pain 2021 · Cochrane Headline outcomes only
RR 0.94 [0.66, 1.3]
1 study · 200 participants
Very low

Nausea · people with moderate to severe cancer pain

The review found no eligible studies for this question.

1 finding from 1 review

Hydromorphone for cancer pain 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Nausea · people with moderate to severe cancer pain

It is very uncertain whether hydromorphone changes specific adverse events – nausea compared with oxycodone (very low certainty).

1 finding from 1 review

Hydromorphone for cancer pain 2021 · Cochrane Headline outcomes only
RR 1.13 [0.74, 1.73]
3 studies · 622 participants
Very low